1. Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy
- Author
-
François Quenet, Carine Arnaudguilhem, Nabila Bouazza, Marta Jarlier, Olivia Sgarbura, Sandra Mounicou, Brice Bouyssiere, Sonia Boulabas, Marion Larroque, Institut des sciences analytiques et de physico-chimie pour l'environnement et les materiaux (IPREM), Université de Pau et des Pays de l'Adour (UPPA)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut du Cancer de Montpellier (ICM), UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle (ICM), and CRLCC Val d'Aurelle - Paul Lamarque
- Subjects
Medical staff ,Occupational hazard ,medicine.medical_treatment ,Statistical difference ,PIPAC ,Antineoplastic Agents ,Urine ,Toxicology ,01 natural sciences ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,Drug Delivery Systems ,Risk Factors ,[CHIM.ANAL]Chemical Sciences/Analytical chemistry ,Occupational Exposure ,Personal protective equipment ,Medical Staff, Hospital ,Pressure ,Medicine ,Humans ,[CHIM]Chemical Sciences ,Trial registration ,Occupational safety ,Occupational Health ,Peritoneal Neoplasms ,Pharmacology ,Aerosols ,Chemotherapy ,Inhalation ,business.industry ,010401 analytical chemistry ,Housekeeping, Hospital ,Contamination ,3. Good health ,0104 chemical sciences ,Oxaliplatin ,030220 oncology & carcinogenesis ,Anesthesia ,Case-Control Studies ,Peritoneum ,business ,medicine.drug ,Environmental Monitoring - Abstract
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a technique to directly deliver chemotherapeutic drugs in the abdomen for the treatment of peritoneal metastases. Pressurization improves the treatment efficacy but increases the risk of exposure for the medical/non-medical staff who can be exposed by dermal or ocular contact, or inhalation of aerosols containing the cytotoxic drugs. The aim of this study was to evaluate the risk of exposure for the medical/non-medical staff (nurses, surgeons, anaesthesiologists and cleaning personnel; n = 13) during PIPAC with oxaliplatin performed according to the protocol recommended in France. Blood samples were collected 1 h before and immediately after PIPAC, and urine samples 1 h before, and then 3 h and the morning after PIPAC. In the control, non-exposed group (n = 7), only one urine and blood sample were collected. Surface contamination in the operating room was assessed in water- and Surfanios-impregnated wipe samples. The total elemental platinum in each sample was quantified by inductively coupled plasma mass spectrometry, using a method adapted to quantify trace amounts (ng.L−1) in very low volumes (100 μl). No surface contamination was detected. Although 25% of urine samples in the exposed group contained platinum, no statistical difference was observed in urine and plasma samples collected before and after PIPAC and with the control group samples. These findings suggest that the French PIPAC protocol does not increase the risk of exposure to platinum in all staff categories involved. This protocol could be considered in future occupational policies and consensus statements. Trial registration: NCT04014426
- Published
- 2021
- Full Text
- View/download PDF